Business Context and Reporting Period
Company: SELLAS Life Sciences Group, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 3, 2025
Reporting Period: This filing reports a specific corporate event occurring on June 3, 2025, rather than a standard financial reporting period.
Key Financial Metrics
This Form 8-K does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The filing is strictly informational regarding a change in the company's independent registered public accounting firm.
Material Changes
- Change in Certifying Accountant: On June 3, 2025, the Company's former auditor, Moss Adams LLP, merged with BakerTilly US, LLP. Consequently, Moss Adams resigned as the Company's auditor.
- Appointment of Successor: The Audit Committee accepted the resignation of Moss Adams and appointed Baker Tilly US, LLP as the successor independent registered public accounting firm for the fiscal year ending December 31, 2025.
- Audit History: Moss Adams' audit reports for the years ended December 31, 2024, and 2023, did not contain adverse opinions, disclaimers, or qualifications. However, the reports included an explanatory paragraph regarding a going concern uncertainty.
- Disagreements: There were no disagreements with Moss Adams regarding accounting principles, financial statement disclosures, or auditing scope/procedures during the fiscal years 2023-2024 or the subsequent interim period.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms that the transition of the audit firm was due to a merger between the two accounting firms. The Company engaged Baker Tilly immediately following the resignation of Moss Adams.
Risks and Contingencies: The filing explicitly notes that prior audit reports contained an explanatory paragraph regarding a going concern uncertainty. No new risks or contingencies were disclosed in this specific report.
Consultations: The Company did not consult with Baker Tilly regarding accounting principles, disagreements, or reportable events prior to their appointment.
Investor Verification Checklist
- Verify the status of the "going concern uncertainty" noted in the 2023 and 2024 audit reports to assess current liquidity risks.
- Review the letter from Moss Adams (Exhibit 16.1) to confirm their agreement with the Company's statements regarding the change in auditors.
- Monitor upcoming financial filings (10-Q or 10-K) to see if the new auditor, Baker Tilly, issues any modified opinions or new going concern warnings.
- Confirm that no undisclosed disagreements or reportable events occurred during the interim period leading up to June 3, 2025.